CORONARY STENT AND PROSTHETIC HEART VALVE INFORMATION VIA SMARTPHONE NEW APPLICATIONS IMPROVING HEALTH-CARE QUALITY OF PATIENTS HAVING UNDERGONE PERCUTANEOUS CORONARY INTERVENTION AND ARTIFICIAL VALVE REPLACEMENT

Authors

  • Hiroshi Imagawa Intelligent Medical Application & Yagi Neuro-surgical Hospital, Osaka, Japan
  • Takayoshi Yagi Yagi Neuro-surgical Hospital, Osaka, Japan
  • Hirokatsu Taniguchi Yagi Neuro-surgical Hospital, Osaka, Japan

DOI:

https://doi.org/10.20319/mijst.2017.s31.224234

Keywords:

Heart Disease, Cardiac Surgery, Percutaneous Coronary Intervention, Coronary Stent, Prosthetic Heart Valve, Health-Care

Abstract

There are a huge number of patients who have been treated by percutaneous coronary intervention (PCI) with stenting. Many studies have reported that cessation of antiplatelet medications produces in-stent thrombosis in patients, especially those with drug-eluting stent. Also, patients with mechanical prosthetic valves must not stop the anticoagulant therapy even in the late postoperative period, irrespective of type of the valve or position in the heart. However some people voluntarily abandon taking the antiplatelet or the anticoagulant medicines when they encounter an unexpected emergent medical problem. We have made a hypothesis that smartphone based ubiquitous system of recording coronary stent information and prosthetic heart valve data would be useful in managing patients, who underwent PCI or artificial heart valve surgery. We developed smartphone applications archiving PCI and prosthetic heart valve data, “Coronary Stent Information” and “Prosthetic Heart Valve Information”, respectively. These simple and free applications run on iOS or Android. More than eighty percent of participants approved one of these applications. We concluded that coronary stent and prosthetic heart valve data recording systems using smartphone technology are simple and valuable methods in managing people suffering from ischemic or valvular heart disease. These ubiquitous applications would improve health-care quality of patients who have undergone PCI and prosthetic heart valve surgery.

References

Ai, A. L., Hopp, F., & Shearer, M. (2006). Getting Affairs in Order. Journal of Social Work in End-Of-Life & Palliative Care, 2(1), 71-94. doi:https://doi.org/10.1300/J457v02n01_06

Al-Badarneh, A., Najadat, H., & Yabes', E. '. (2017). An Adaptive Role-Based Access Control Approach For Cloud E-Health Systems. LIFE: International Journal of Health and Life-Sciences, 2(3), 26-37. doi:https://doi.org/10.20319/lijhls.2016.23.2637

Aramide, G., Shona, K., Keith, B., & Teresa, B. (2016). Identify The Risk To Hospital Admission In Uk-Systematic Review Of Literature. LIFE: International Journal of Health and Life-Sciences, 2(2), 20-34. doi:https://doi.org/10.20319/lijhls.2016.22.2034

Baars, J. (2016). Aging: Learning to Live a Finite Life. The Gerontologist GERONT. doi:https://doi.org/10.1093/geront/gnw089

Bayliss, A., Faber, P., Dunning, J., et al. (2007). What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve? Interactive CardioVascular and Thoracic Surgery, 6(3), 390-396. doi:https://doi.org/10.1510/icvts.2007.152819

Brodie, B. R., et al. (2008). Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: Results from the Strategic Transcatheter Evaluation of New Therapies (STENT) Group. Cathet. Cardiovasc. Intervent. Catheterization and Cardiovascular Interventions, 72(7), 893-900. doi:https://doi.org/10.1002/ccd.21767

Cheng, V. E., Oppermen, A., Natarajan, D., et al. (2014). Spontaneous Omental Bleeding in the Setting of Dual Anti-platelet Therapy with Ticagrelor. Heart, Lung and Circulation, 23(4). doi: https://doi.org/10.1016/j.hlc.2013.11.002

Chesebro, J. H., Adams, P. C., & Fuster, V. (1986). Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves. Journal of the American College of Cardiology, 8(6). doi: https://doi.org/10.1016/S0735-1097(86)80006-7

Cranwell, K., Polacsek, M., & Mccann, T. V. (2016). Improving care planning and coordination for service users with medical co-morbidity transitioning between tertiary medical and primary care services. J. Psychiatr. Ment. Health Nurs. Journal of Psychiatric and Mental Health Nursing. doi: https://doi.org/10.1111/jpm.12322

Forman, D. E., & Alexander, K. P. (2016). Frailty: A Vital Sign for Older Adults With Cardiovascular Disease. Canadian Journal of Cardiology, 32(9), 1082-1087. doi: https://doi.org/10.1016/j.cjca.2016.05.015

Hordern, V. (2016). Data Protection Compliance in the Age of Digital Health. European Journal of Health Law, 23(3), 248-264. doi:https://doi.org/10.1163/15718093-12341393

Kupferwasser, L. I., et al. (2007). Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Cathet. Cardiovasc. Intervent. Catheterization and Cardiovascular Interventions, 70(1), 1-8. doi:https://doi.org/10.1002/ccd.21083

Lund, O., & Bland, M. (2006). Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery, 132(1). doi:https://doi.org/10.1016/j.jtcvs.2006.01.043

Morton, L. (2002). Importance of emergency identification schemes. Emergency Medicine Journal, 19(6), 584-586. doi:https://doi.org/10.1136/emj.19.6.584

Neame, R. (1997). Smart cards?the key to trustworthy health information systems. Bmj, 314(7080), 573-573. doi:https://doi.org/10.1213/ane.0b013e3181731e95

Newsome, L. T., Weller, R. S., Gerancher, J. C., Kutcher, M. A., & Royster, R. L. (2008). Coronary Artery Stents: II. Perioperative Considerations and Management. Anesthesia & Analgesia, 107(2), 570-590. doi:https://doi.org/10.3402/ijch.v63i4.17747

Olsson, S., Lymberis, A., & Whitehouse, D. (2004). European Commission activities in eHealth. International Journal of Circumpolar Health, 63(4). doi: https://doi.org/10.3402/ijch.v63i4.17747

Schofer, J., Bode, C., & Silber, S. (2004). Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction. Herz, 29(2), 195-200. doi:10.1007/s00059-004-2570-8 https://doi.org/10.1007/s00059-004-2570-8

Valgimigli, M., et al. (2014). Two-Year Outcomes After First- or Second-Generation Drug-Eluting or Bare-Metal Stent Implantation in All-Comer Patients Undergoing Percutaneous Coronary Intervention. JACC: Cardiovascular Interventions, 7(1), 20-28. doi:https://doi.org/10.1016/j.jcin.2013.09.008

Yamaji, K., et al. (2016). Ten-year clinical outcomes of first-generation drug-eluting stents: The Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial. Eur Heart J European Heart Journal. doi:https://doi.org/10.1093/eurheartj/ehw343

Zhao, D. F., et al. (2016). Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis. The Annals of Thoracic Surgery, 102(1), 315-327. doi:https://doi.org/10.1016/j.athoracsur.2015.10.092

Downloads

Published

2017-05-17

How to Cite

Imagawa, H., Yagi Takayoshi, ., & Taniguchi, H. (2017). CORONARY STENT AND PROSTHETIC HEART VALVE INFORMATION VIA SMARTPHONE NEW APPLICATIONS IMPROVING HEALTH-CARE QUALITY OF PATIENTS HAVING UNDERGONE PERCUTANEOUS CORONARY INTERVENTION AND ARTIFICIAL VALVE REPLACEMENT. MATTER: International Journal of Science and Technology, 3(1), 224–234. https://doi.org/10.20319/mijst.2017.s31.224234